Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A novel combination for relapsed/refractory multiple myeloma produced responses in about 80% of a heavily treated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback